TFF3 and early-onset autosomal dominant Alzheimer disease: Clinical findings have shown that TFF3 is the strongest predictor of neurodegeneration across the spectrum of cerebral amyloidosis, with significant reductions in TFF3 levels observed in patients with vascular parkinsonism dementia, Parkinson’s disease dementia, and Alzheimer’s disease [37, 38].